Search - tctmd.com

Displaying 21 - 40 of 4092

Sort: Relevancy | Date

News Daily News

Experience Matters as Ross Procedure Gains Popularity in North America

Michael O'Riordan

March 06, 2026

Podcast TCTMD Talking Points

The CorCMR Trial

March 04, 2026

Presentation THT 2026

RV Response in Valvular Heart Disease

Presenter: Michael I. Brener

March 04, 2026

News Daily News

Healthy Lifestyle Plus GLP-1s Yields Bigger CV Reduction Than Drugs Alone

Michael O'Riordan

March 03, 2026

Presentation THT 2026

Ice Is Still an Option for Cold Preservation

Presenter: Michael Tong

March 03, 2026

Presentation THT 2026

Baseline Characteristics and Outcomes in Patients Presenting with Cardiogenic Shock: A Single-Center Cohort Study

Presenter: Michael Daidone

March 03, 2026

Presentation THT 2026

An Emerging Problem: TR in Advanced Heart Failure (LVAD, OHT) Patients

Presenter: Michael I. Brener

March 03, 2026

Presentation THT 2026

Novel Prediction Model for In-Hospital Mortality in Cardiogenic Shock Patients

Presenter: Michael Daidone

March 03, 2026

Presentation THT 2026

The Role of the Myocardium in HFpEF

Presenter: Michael R. Zile

March 03, 2026

Presentation THT 2026

Preclinical Results of a Novel, Percutaneous Device to Reapproximate and Reshape the Right Ventricle in Functional Tricuspid Regurgitation with Right Ventricular Dysfunction

Presenter: Michael I. Brener

March 03, 2026

Presentation THT 2026

What Needs to be Shown in Studies of ADHF Devices to Gain FDA Approval and Adoption Into Clinical Practice

Presenter: G. Michael Felker

March 03, 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2026

Michael O'Riordan

March 02, 2026

Presentation THT 2026

Relationship Between Remote, Ambulatory Pulmonary Artery Pressures, and the Risk of Heart Failure Hospitalizations in Patients With Chronic Heart Failure

Presenter: Michael R. Zile

March 02, 2026

Presentation THT 2026

Framing Thoughts From the Experts

Presenter: Michael I. Brener

March 02, 2026

Presentation THT 2026

Worsening heart failure and subsequent heart failure events

Presenter: Michael Stanley Kiernan

March 02, 2026

News Daily News

Radiation Doses for CAD Diagnostic Tests Vary Widely Worldwide

Michael O'Riordan

February 27, 2026

News Daily News

Surgical Mitral Valve Repair Outcomes ‘Excellent’ at 2 Years: CTSN

Yael L. Maxwell

February 26, 2026

News Features

Holding Out Hope for HF Shunts, Even After an FDA Panel’s Doubts

Michael O'Riordan

February 24, 2026

News Daily News

Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial

Michael O'Riordan

February 19, 2026

News Daily News

Transfer Delays Tied to Worse Acute Stroke Intervention Results

Todd Neale

February 18, 2026

Advertisement

Experience Matters as Ross Procedure Gains Popularity in North America

The CorCMR Trial

RV Response in Valvular Heart Disease

Healthy Lifestyle Plus GLP-1s Yields Bigger CV Reduction Than Drugs Alone

Ice Is Still an Option for Cold Preservation

Baseline Characteristics and Outcomes in Patients Presenting with Cardiogenic Shock: A Single-Center Cohort Study

An Emerging Problem: TR in Advanced Heart Failure (LVAD, OHT) Patients

Novel Prediction Model for In-Hospital Mortality in Cardiogenic Shock Patients

The Role of the Myocardium in HFpEF

Preclinical Results of a Novel, Percutaneous Device to Reapproximate and Reshape the Right Ventricle in Functional Tricuspid Regurgitation with Right Ventricular Dysfunction

What Needs to be Shown in Studies of ADHF Devices to Gain FDA Approval and Adoption Into Clinical Practice

TCTMD’s Top 10 Most Popular Stories for February 2026

Relationship Between Remote, Ambulatory Pulmonary Artery Pressures, and the Risk of Heart Failure Hospitalizations in Patients With Chronic Heart Failure

Framing Thoughts From the Experts

Worsening heart failure and subsequent heart failure events

Radiation Doses for CAD Diagnostic Tests Vary Widely Worldwide

Surgical Mitral Valve Repair Outcomes ‘Excellent’ at 2 Years: CTSN

Holding Out Hope for HF Shunts, Even After an FDA Panel’s Doubts

Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial

Transfer Delays Tied to Worse Acute Stroke Intervention Results

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content